# K143208: Denali Filter System - Femoral Delivery Kit, Denali Filter System - Jugular/Subclavain Delivery Kit

- Pathway: 510(k) (Special)
- Applicant: C.R. Bard, Inc.
- Decided: Dec 9, 2014 after 29 days
- Product code: DTK (Filter, Intravascular, Cardiovascular)
- Device class: 2
- Regulation: 21 CFR 870.3375
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 9 generations back to K022236 (2002). 11 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 14 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K130366: Bard Denali Filter System- Femoral Delivery Kit and Jugular Delivery Kit, C.R. Bard, Inc. (2013) Summary page 4.

## Most influential descendants
- K160866: Denali Filter System - Femoral Delivery Kit, Denali Filter System - Jugular/Subclavian Delivery Kit (2016), 1 descendant of its own
- K240257: Denali™ Vena Cava Filter System – Femoral and Jugular/Subclavian Delivery Kit (2024), 0 descendants of its own

## Indications for use
The Denali® Filter is indicated for use in the prevention of recurrent pulmonary embolism via placement in the vena cava in the following situations: -Pulmonary thromboembolism when anticoagulants are contraindicated. -Failure of anticoagulant therapy for thromboembolic disease. -Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced. -Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated. The Denali® Filter may be removed according to the instructions supplied under the Section labeled: Optional Procedure for Filter Removal.

Source page: https://510kreport.com/device/K143208
Methodology: https://510kreport.com/methodology